Adicet Bio Capital Expenditures (CapEx) Growth & History (ACET)
Adicet Bio's capital expenditures (capex) was $1.7M for fiscal 2025.
View full Adicet Bio company overviewAdicet Bio annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.7M | $620,000 | +55.46% |
| 2024 | 2024-12-31 | $1.1M | −$3.3M | −74.96% |
| 2023 | 2023-12-31 | $4.5M | −$12.3M | −73.40% |
| 2022 | 2022-12-31 | $16.8M | $3.7M | +28.64% |
| 2021 | 2021-12-31 | $13.0M | $12.1M | +1217.78% |
| 2020 | 2020-12-31 | $990,000 | −$80,000 | −7.48% |
| 2019 | 2019-12-31 | $1.1M | $194,000 | +22.15% |
| 2018 | 2018-12-31 | $876,000 | $832,000 | +1890.91% |
| 2017 | 2017-12-31 | $44,000 | — | — |
Adicet Bio quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $202,000 | $155,000 | +329.79% |
| Q1 2026 | 2026-03-31 | $37,000 | −$1.5M | −97.52% |
| Q4 2025 | 2025-12-31 | $10,000 | −$166,000 | −94.32% |
| Q3 2025 | 2025-09-30 | $209,000 | −$192,000 | −47.88% |
| Q2 2025 | 2025-06-30 | $47,000 | −$255,000 | −84.44% |
| Q1 2025 | 2025-03-31 | $1.5M | $1.3M | +524.27% |
| Q4 2024 | 2024-12-31 | $176,000 | $40,000 | +29.41% |
| Q3 2024 | 2024-09-30 | $401,000 | −$505,000 | −55.74% |
| Q2 2024 | 2024-06-30 | $302,000 | −$1.2M | −79.96% |
| Q1 2024 | 2024-03-31 | $239,000 | −$1.7M | −87.52% |
| Q4 2023 | 2023-12-31 | $136,000 | −$6.4M | −97.90% |
| Q3 2023 | 2023-09-30 | $906,000 | −$3.9M | −81.17% |
| Q2 2023 | 2023-06-30 | $1.5M | −$1.3M | −47.10% |
| Q1 2023 | 2023-03-31 | $1.9M | −$717,000 | −27.24% |
| Q4 2022 | 2022-12-31 | $6.5M | $3.4M | +110.85% |
| Q3 2022 | 2022-09-30 | $4.8M | −$2.4M | −32.98% |
| Q2 2022 | 2022-06-30 | $2.8M | $717,000 | +33.63% |
| Q1 2022 | 2022-03-31 | $2.6M | $2.0M | +300.00% |
| Q4 2021 | 2021-12-31 | $3.1M | $2.7M | +755.00% |
| Q3 2021 | 2021-09-30 | $7.2M | $7.0M | +3192.66% |
| Q2 2021 | 2021-06-30 | $2.1M | $2.0M | +1722.22% |
| Q1 2021 | 2021-03-31 | $658,000 | $363,000 | +123.05% |
| Q4 2020 | 2020-12-31 | $360,000 | −$99,000 | −21.57% |
| Q3 2020 | 2020-09-30 | $218,000 | −$345,000 | −61.28% |
| Q2 2020 | 2020-06-30 | $117,000 | $93,000 | +387.50% |
| Q1 2020 | 2020-03-31 | $295,000 | $271,000 | +1129.17% |
| Q4 2019 | 2019-12-31 | $459,000 | −$84,000 | −15.47% |
| Q3 2019 | 2019-09-30 | $563,000 | $534,000 | +1841.38% |
| Q2 2019 | 2019-06-30 | $24,000 | −$2,000 | −7.69% |
| Q1 2019 | 2019-03-31 | $24,000 | −$254,000 | −91.37% |
| Q4 2018 | 2018-12-31 | $543,000 | — | — |
| Q3 2018 | 2018-09-30 | $29,000 | $17,000 | +141.67% |
| Q2 2018 | 2018-06-30 | $26,000 | — | — |
| Q1 2018 | 2018-03-31 | $278,000 | — | — |
| Q3 2017 | 2017-09-30 | $12,000 | — | — |
Adicet Bio capital expenditures (capex) trends
Over the last five fiscal years, Adicet Bio's capital expenditures (capex) increased from $990,000 to $1.7M, a change of $748,000. The latest reported quarter, Q2 2026, shows $202,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Adicet Bio source filings ↗